Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  trivalent influenza vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-13 of 13 for your search:
Start Over
Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients
Phase: Phase II
Type: Supportive care
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: Eudract number: 2006-004902-16, LREC number: 06/Q2201/143, NCT00596336
Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 65 and over
Sponsor: Other
Protocol IDs: 08-005, NCT00741039
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 3 to 21
Sponsor: Other
Protocol IDs: FLUHD, NCT01205581
Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 to 64
Sponsor: Pharmaceutical / Industry
Protocol IDs: CIC 1336-B12-1, NCT01666782
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 1 to 20 at time of diagnosis
Sponsor: NCI, Other
Protocol IDs: RP 99-12, RPCI-RP-9912, NCI-G01-1990, NCT00022035
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
Phase: No phase specified
Type: Health services research, Prevention
Status: Completed
Age: 12 to 26
Sponsor: Other
Protocol IDs: Pro00011038, NCT00828555
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 06157, P30CA033572, CHNMC-06157, CDR0000652790, NCT00964821
Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor
Phase: No phase specified
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCNONCO20084, NCT00979381
Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: RIFLUVAC, version 2, 21-08-09, NCT01000246
Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98411, NCI-2011-03033, NCT01474174
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Closed
Age: 18 to 64
Sponsor: NCI, Other
Protocol IDs: I 203111, NCI-2011-03232, NCT01561989
Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NL37320.100.11, NCT01707628
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Closed
Age: 18 to 120
Sponsor: NCI, Other
Protocol IDs: CCCWFU 97413, NCI-2013-01740, P30CA012197, NCT01941758
Start Over